Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTYX Ventyx Biosciences, Inc.

交易中 12-20 09:34:51 EST

2.30

+0.02

+0.88%

最高2.30	最低2.26	成交量8.27万
今开2.27	昨收2.28	日振幅1.75%
总市值1.63亿	流通市值1.14亿	总股本7,071万
成交额18.77万	换手率0.17%	流通股本4,944万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTYX","market":"US","secType":"STK","nameCN":"Ventyx Biosciences, Inc.","latestPrice":2.3,"timestamp":1734705283209,"preClose":2.28,"halted":0,"volume":82691,"delay":0,"floatShares":49439901,"shares":70710667,"eps":-2.327124,"marketStatus":"交易中","marketStatusCode":2,"change":0.02,"latestTime":"12-20 09:34:51 EST","open":2.27,"high":2.3,"low":2.26,"amount":187742.8536886,"amplitude":0.017544,"askPrice":2.31,"askSize":2300,"bidPrice":2.27,"bidSize":310,"shortable":3,"etf":0,"ttmEps":-2.327124,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"listingDate":1634788800000,"adjPreClose":2.28,"preHourTrading":{"tag":"盘前","latestPrice":2.2992,"preClose":2.28,"latestTime":"09:06 EST","volume":2287,"amount":5374.546054,"timestamp":1734703607813},"postHourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.28,"latestTime":"19:48 EST","volume":909505,"amount":2073701.02,"timestamp":1734655732473},"volumeRatio":4.749373,"impliedVol":2.3082,"impliedVolPercentile":0.9405},"requestUrl":"/m/hq/s/VTYX/tweets","defaultTab":"tweets","newsList":[{"id":"2492413290","title":"Ventyx Biosciences, Inc.盘中异动 下午盘急速拉升5.06%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492413290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492413290?lang=zh_cn&edition=full","pubTime":"2024-12-19 02:16","pubTimestamp":1734545811,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日02时16分，Ventyx Biosciences, Inc.股票出现异动，股价急速上涨5.06%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，Polyrizon Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cognition Therapeutics, Inc.涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3040.56%、617.89%、337.99%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、118.27%、105.17%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121902165195ea5814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121902165195ea5814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2492993932","title":"Ventyx Biosciences, Inc.盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492993932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492993932?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:25","pubTimestamp":1734456347,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时25分，Ventyx Biosciences, Inc.股票出现波动，股价急速上涨5.11%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.涨幅较大，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃，换手率分别为2408.42%、356.41%、143.67%，振幅较大的相关个股有Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为211.53%、153.77%、95.10%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218012547984c92e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218012547984c92e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2491590353","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491590353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491590353?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:34","pubTimestamp":1734028452,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时34分，Ventyx Biosciences, Inc.股票出现异动，股价急速下挫5.75%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Trevi Therapeutics, Inc.、Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3954.51%、1116.79%、90.33%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、95.90%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213023412a1e9bc44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213023412a1e9bc44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2490586287","title":"Ventyx Biosciences, Inc.盘中异动 早盘快速下跌5.03%报2.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490586287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490586287?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:26","pubTimestamp":1733930774,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时26分，Ventyx Biosciences, Inc.股票出现异动，股价快速跳水5.03%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211232615ab6fe618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211232615ab6fe618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2490433660","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.32%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490433660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490433660?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:04","pubTimestamp":1733843090,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时04分，Ventyx Biosciences, Inc.股票出现异动，股价快速下跌5.32%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.22%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1884.65%、430.34%、103.37%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd.，振幅分别为138.72%、131.78%、38.65%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230450984b0da6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230450984b0da6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2490771608","title":"Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490771608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490771608?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:40","pubTimestamp":1733755253,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时40分，Ventyx Biosciences, Inc.股票出现异动，股价大幅上涨5.07%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224053a1e0ad45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224053a1e0ad45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2489232569","title":"Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.18%报2.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489232569","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489232569?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:24","pubTimestamp":1733498660,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时24分，Ventyx Biosciences, Inc.股票出现异动，股价急速上涨5.18%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Adc Therapeutics Sa、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Cervomed Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.42%、40.07%、27.54%，振幅较大的相关个股有Adc Therapeutics Sa、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为33.33%、27.68%、26.58%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232420ab62f131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232420ab62f131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2489237149","title":"Ventyx Biosciences, Inc.盘中异动 下午盘股价大涨5.22%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489237149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489237149?lang=zh_cn&edition=full","pubTime":"2024-12-05 03:24","pubTimestamp":1733340291,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日03时24分，Ventyx Biosciences, Inc.股票出现波动，股价快速上涨5.22%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Exicure, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为4423.57%、281.76%、144.11%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为548.98%、287.57%、64.57%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205032451ab5db3ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205032451ab5db3ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2488608884","title":"Ventyx Biosciences, Inc.盘中异动 早盘大幅下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488608884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488608884?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:16","pubTimestamp":1733152585,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时16分，Ventyx Biosciences, Inc.股票出现波动，股价快速下跌5.59%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Kyverna Therapeutics, Inc.涨幅较大，Senti Biosciences, Inc.、Revelation Biosciences, Inc.、Cabaletta Bio, Inc.较为活跃，换手率分别为1531.56%、220.77%、21.09%，振幅较大的相关个股有Senti Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为481.02%、64.17%、45.18%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223162698e4ed50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223162698e4ed50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2486827387","title":"Ventyx Biosciences, Inc.盘中异动 急速下挫5.12%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486827387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486827387?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:31","pubTimestamp":1732717878,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时31分，Ventyx Biosciences, Inc.股票出现异动，股价大幅跳水5.12%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为791.13%、24.34%、6.87%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Elevai Labs, Inc.、Immutep Ltd，振幅分别为13.97%、8.20%、6.81%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223118971a8db9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223118971a8db9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2486038211","title":"Ventyx Biosciences, Inc.盘中异动 急速拉升5.14%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038211?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:46","pubTimestamp":1732545966,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时46分，Ventyx Biosciences, Inc.股票出现波动，股价快速上涨5.14%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522460698e446b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522460698e446b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2485292157","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485292157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485292157?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:12","pubTimestamp":1732299137,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时12分，Ventyx Biosciences, Inc.股票出现异动，股价大幅拉升5.20%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、Candel Therapeutics, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1875.45%、153.84%、95.97%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Virpax Pharmaceuticals, Inc.，振幅分别为82.83%、77.41%、72.75%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112302121798e4436f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112302121798e4436f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2484115602","title":"Ventyx Biosciences, Inc.盘中异动 下午盘股价大跌5.35%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484115602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484115602?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:46","pubTimestamp":1731955563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时46分，Ventyx Biosciences, Inc.股票出现异动，股价急速跳水5.35%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，冠科美博、Hcw Biologics Inc.、Tharimmune, Inc.较为活跃，换手率分别为1269.05%、1208.85%、567.31%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为563.48%、221.58%、193.44%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024603971a7413&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024603971a7413&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2483538276","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.08%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483538276?lang=zh_cn&edition=full","pubTime":"2024-11-16 04:59","pubTimestamp":1731704392,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日04时59分，Ventyx Biosciences, Inc.股票出现异动，股价快速下挫5.08%。截至发稿，该股报1.87美元/股，成交量103.958万股，换手率1.47%，振幅6.09%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.64%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116045952a23c0bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116045952a23c0bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2481988832","title":"Ventyx Biosciences, Inc.盘中异动 早盘大幅拉升6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988832?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903559,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Ventyx Biosciences, Inc.股票出现波动，股价大幅上涨6.42%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、100.21%、52.15%，振幅较大的相关个股有Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为107.84%、106.06%、106.04%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223239971a4bfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223239971a4bfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2480818252","title":"Ventyx Biosciences Inc    预计每股亏损 52 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480818252","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480818252?lang=zh_cn&edition=full","pubTime":"2024-11-02 12:05","pubTimestamp":1730520353,"startTime":"0","endTime":"0","summary":"   * Ventyx Biosciences Inc    预计在11月4日公布截至2024年9月30日的财报() 时，季度收入不会有变化。*    * LSEG分析师对Ventyx Biosciences Inc的平均预期是每股亏损52美分。* 目前分析师对该公司股票的平均评级为 \"买入\"，建议的细目为6个 \"强烈买入 \"或 \"买入\"，3个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Ventyx Biosciences Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 2.15 美元。11月2日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ventyx Biosciences Inc    预计每股亏损 52 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX"],"gpt_icon":0},{"id":"2479102235","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479102235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479102235?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:23","pubTimestamp":1730219028,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时23分，Ventyx Biosciences, Inc.股票出现波动，股价急速上涨5.19%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002349a1f61623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002349a1f61623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2478730438","title":"Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.05%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478730438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478730438?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:20","pubTimestamp":1730128803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时20分，Ventyx Biosciences, Inc.股票出现异动，股价快速上涨5.05%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823200498e3edeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823200498e3edeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2477635499","title":"Ventyx Biosciences, Inc.盘中异动 临近午盘急速下跌5.23%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477635499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477635499?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:42","pubTimestamp":1729611750,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时42分，Ventyx Biosciences, Inc.股票出现波动，股价急速跳水5.23%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4854.40%、4375.29%、2002.54%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为170.68%、101.99%、99.41%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022234230a1e2d54a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022234230a1e2d54a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2477986767","title":"Ventyx Biosciences, Inc.盘中异动 早盘大幅下跌5.09%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477986767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477986767?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:17","pubTimestamp":1729523869,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时17分，Ventyx Biosciences, Inc.股票出现异动，股价大幅下跌5.09%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5703.11%、3001.96%、1292.68%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123174998e3d91d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123174998e3d91d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.ventyxbio.com","stockEarnings":[{"period":"1week","weight":-0.0656},{"period":"1month","weight":0.2809},{"period":"3month","weight":-0.0087},{"period":"6month","weight":-0.0916},{"period":"1year","weight":0.0962},{"period":"ytd","weight":-0.0769}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ventyx Biosciences, Inc.于2018年11月21日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于为数百万患有炎症性疾病和自身免疫性疾病的患者开发新疗法。该公司相信，他们有选择性地调节关键免疫靶点以创造差异化药物的能力将使他们有可能破坏成熟的价值数十亿美元的商业市场，并使他们成为免疫学市场的领导者。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.01538},{"month":2,"riseRate":0.666667,"avgChangeRate":0.701385},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.095926},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.042289},{"month":5,"riseRate":0.666667,"avgChangeRate":0.133308},{"month":6,"riseRate":0,"avgChangeRate":-0.288909},{"month":7,"riseRate":1,"avgChangeRate":0.12313},{"month":8,"riseRate":0.333333,"avgChangeRate":0.07183},{"month":9,"riseRate":0.666667,"avgChangeRate":0.241856},{"month":10,"riseRate":0,"avgChangeRate":-0.222243},{"month":11,"riseRate":0.25,"avgChangeRate":-0.186714},{"month":12,"riseRate":0.75,"avgChangeRate":0.034008}],"exchange":"NASDAQ","name":"Ventyx Biosciences, Inc.","nameEN":"Ventyx Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ventyx Biosciences, Inc.,VTYX,Ventyx Biosciences, Inc.股票,Ventyx Biosciences, Inc.股票老虎,Ventyx Biosciences, Inc.股票老虎国际,Ventyx Biosciences, Inc.行情,Ventyx Biosciences, Inc.股票行情,Ventyx Biosciences, Inc.股价,Ventyx Biosciences, Inc.股市,Ventyx Biosciences, Inc.股票价格,Ventyx Biosciences, Inc.股票交易,Ventyx Biosciences, Inc.股票购买,Ventyx Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}